Hyperuricemia facilitates the prediction of maternal and perinatal adverse outcome in patients with severe/superimposed preeclampsia

References

• Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP, Daftary AR, Roberts JM. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 2006;194:160.
   PubMed Web of Science ®Google Scholar
• Lam C, Lim KH, Hank GH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol 2005;25:56–60.
   PubMed Web of Science ®Google Scholar
• Voto LS, Illia R, Darbon-Grosso HA, Imaz FU, Margulies M. Uric acid levels; a useful index of the severity of preeclampsia and perinatal prognosis. J Perninat Med 1988;16:123–126.
   PubMed Web of Science ®Google Scholar
• Paula LG, da Costa BEP, Poli-de-Figueiredo CE, Antonello ICF. Does uric acid provide information about maternal condition and fetal outcome in pregnant women with hypertension. Hypertens Pregnancy 2008;27:413–420.
   PubMed Web of Science ®Google Scholar
• Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J, Johnson RJ. Uric acid, endothelial dysfunction and pre-elampsia: searching for a pathogenetic link. J Hypertens 2004;22:229–235.
   PubMed Web of Science ®Google Scholar
• Liedholm H, Montan S, Aberg A. Risk grouping of 113 patients with hypertensive disorders during pregnancy, with respect to serum urate, proteinuria and time of onset of hypertension. Acta Obstet Gyencol Scan Suppl 1984;63(Suppl 118):43–48.
   Google Scholar
• Redman CW, Beilin LJ, Bonnar J, Wilkinson RH. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976;1:1370–1373.
   PubMed Web of Science ®Google Scholar
• Williams KP, Galerneau F. The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies. J Obstet Gynaecol Can 2002;24:628–634.
   PubMedGoogle Scholar
• Martin JN Jr, May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999;180:1407–1414.
   PubMed Web of Science ®Google Scholar
• Thangaratinam S, Ismail KMK, Sharp S, Coomarasamy A, Khan K. Accuracy of serum uric acid in predicting complications of preeclampsia: a systematic review. BJOG 2006;113:369–378.
   PubMed Web of Science ®Google Scholar
• Stander HF, Cadden JF. Blood chemistry in preeclampsia and eclampsia. Am J Obstet Gynecol 1934;28:856.
   Google Scholar
• Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:127–136.
   PubMed Web of Science ®Google Scholar
• Sagen N, Haram K, Nilsen ST. Serum urate as a predictor of fetal outcome in severe preeclampsia. Acta Obstet Gynecol Scand 1984;63:71–75.
   PubMed Web of Science ®Google Scholar
• Calvert SM, Tuffnell DJ, Haley J. Poor predictive value of platelet count, mean platelet volume and serum urate in hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;64:179–184.
   PubMed Web of Science ®Google Scholar
• Lim KH, Friedman SA, Ecker JL, Kao L, Kilpatrick SJ. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1998;178:1067–1071.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005;46:1263e9.
   Web of Science ®Google Scholar
• Gallery ED, Hunyor SN, Gyory AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med 1979;48:593e602.
   Google Scholar
• Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 1988;254:G768e74.
   Google Scholar
• Simic M, Jovanovic S. Antioxidation mechanisms of uric acid. J Am Chem Soc 1989;111:5778e82.
   Web of Science ®Google Scholar
• Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003;41:1287e93.
   Web of Science ®Google Scholar
• Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183e90.
   Web of Science ®Google Scholar
• Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta 2008;22:S67–S72.
   Google Scholar
• Bainbridge SA, Versen-Höynck FV, Roberts JM. Uric acid inhibits placental system a amino acid uptake. Placenta 2009;30:195–200.
   PubMed Web of Science ®Google Scholar